Skip to main content

Table 3 Cost-effectiveness analysis results

From: Cost-effectiveness analysis of a strategy to delay progression to dialysis and death among chronic kidney disease patients in Lima, Peru

 

Renal Health Program

Standard of care

Difference

Costs (USD, per person)

9357

10,140

− 783

YL (per person)

9.50

9.14

0.36

QALY (per person)

8.19

8.15

0.04

ICER: USD/YL

− 2173

  

ICER: USD/QALY

− 21,660

  
  1. QALY quality-adjusted life year; ICER incremental cost-effectiveness ratio; YL years of life; USD United States Dollars
  2. Costs and ICER values were rounded to the closest integer; YL and QALY values were rounded to two decimals
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us